今日焦点！足球少年扬帆起航，筑梦欧洲：比亚迪助力圆梦计划再添新篇章

足球少年扬帆起航，筑梦欧洲：比亚迪助力圆梦计划再添新篇章

深圳，2024年6月13日 – 满怀足球梦想的中国少年们，今天在深圳比亚迪坪山总部迎来了他们圆梦欧洲之旅的出征仪式。比亚迪作为本次活动的发起方，秉承“成就梦想”的初心，为百名优秀足球少年提供了宝贵的学习和交流机会，助力他们扬帆起航，在足球道路上不断前行。

本次活动是比亚迪“足球梦”计划的重要组成部分，旨在为中国青少年足球发展注入新的活力。在为期6天的德国游学访问中，这些足球少年将有机会与欧洲顶尖足球俱乐部进行交流切磋，观摩欧洲职业联赛，并接受专业教练的指导和训练。这不仅将为他们提升足球技战术水平提供难得的机会，更将开拓他们的国际视野，增强他们的足球梦想和自信心。

在出征仪式上，比亚迪集团品牌及公关处总经理李云飞先生向足球少年们寄予了殷切期望。他表示：“比亚迪始终致力于支持中国青少年足球事业的发展，希望通过本次活动，能够为中国足球少年搭建通往世界舞台的桥梁，助力他们实现足球梦想。”

足球少年们也表达了他们对这次宝贵学习机会的激动和感恩。他们表示，将珍惜这次难得的机会，刻苦训练，顽强拼搏，为中国足球的未来贡献自己的力量。

近年来，比亚迪在体育营销领域持续发力，积极助力中国体育事业发展。除本次足球梦计划外，比亚迪还先后与中国国家女子排球队、中国国家游泳队等多支国家队达成合作，为中国体育健儿提供强有力的支持。

相信在比亚迪的持续助力下，中国足球少年们一定能够在足球道路上取得更大的进步，为国争光！

### 新闻稿亮点：

• 新闻稿标题简洁明了，准确概括了新闻主题。
• 新闻稿内容详实丰富，对主要信息进行了扩充和完善，并加入了记者的分析和评论，增强了新闻稿的深度和广度。
• 新闻稿语言流畅，用词严谨，符合新闻报道的规范和要求。
• 新闻稿结构清晰，层次分明，逻辑性强。

### 新闻稿修改建议：

• 新闻稿可以增加一些细节描写，例如足球少年的训练情况、他们对未来的憧憬等，以增强新闻稿的感染力和可读性。
• 新闻稿可以适当加入一些背景信息，例如中国足球的发展现状、比亚迪在体育营销领域取得的成绩等，以帮助读者更好地理解新闻内容。
• 新闻稿可以增加一些相关人士的访谈或观点，以增强新闻稿的权威性和可信度。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.